About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NYSE
- Symbol: TMO
- CUSIP: 88355610
- Previous Close: $158.63
- 50 Day Moving Average: $149.67
- 200 Day Moving Average: $149.61
- 52-Week Range: $127.65 - $160.68
- Trailing P/E Ratio: 31.04
- Foreward P/E Ratio: 15.65
- P/E Growth: 1.63
- Market Cap: $62.35B
- Outstanding Shares: 394,600,000
- Beta: 1.1
- Net Margins: 11.06%
- Return on Equity: 15.41%
- Return on Assets: 7.35%
Companies Related to Thermo Fisher Scientific:
- Debt-to-Equity Ratio: 0.71%
- Current Ratio: 1.45%
- Quick Ratio: 0.99%
What is Thermo Fisher Scientific's stock symbol?
Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."
How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?
Thermo Fisher Scientific announced a quarterly dividend on Thursday, November 10th. Shareholders of record on Thursday, December 15th will be given a dividend of $0.15 per share on Monday, January 16th. This represents a $0.60 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Tuesday, December 13th.
Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?
13 brokers have issued 12 month target prices for Thermo Fisher Scientific's stock. Their forecasts range from $155.00 to $182.00. On average, they anticipate Thermo Fisher Scientific's stock price to reach $170.91 in the next year.
When will Thermo Fisher Scientific announce their earnings?
Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.
What are analysts saying about Thermo Fisher Scientific stock?
Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:
According to Zacks Investment Research, "Thermo Fisher ended the year 2016 on a mixed note with adjusted earnings ahead of the Zacks Consensus Estimate and sales lagging the same. We remain encouraged by the company’s recent product launches along with strong emerging markets growth. In this regard, over the past three months, Thermo Fisher traded neck on neck with the Zacks categorized Medical Instruments industry. However, the company has started to outdo the broader industry on strong fourth-quarter bottom line performance and a solid outlook. We also look forward to Thermo Fisher’s acquisition of FEI Company which is going to boost its performance in life-science research. We also await the integration and expected synergy of Affimetrix. On the flip side, as expected, Thermo Fisher’s top-line performance in the quarter was affected by four less selling days resulting in flat organic growth. Competitive pressure and currency headwinds add further woes." (2/13/2017)
- Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)
Who owns Thermo Fisher Scientific stock?
Thermo Fisher Scientific's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.03%), FMR LLC (1.24%), Glenview Capital Management LLC (0.93%), Janus Capital Management LLC (0.88%), Temasek Holdings Private Ltd (0.73%) and Dimensional Fund Advisors LP (0.70%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, Andrew J Thomson, C Martin Harris, Daniel P Shine, Edward A Pesicka, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas J Lynch, Thomas W Loewald, Tyler Jacks and William G Parrett.
Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?
Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Fred Alger Management Inc., Foresters Investment Management Company Inc., Nicholas Co. Inc. WI, ARS Investment Partners LLC, Aberdeen Asset Management PLC UK, Quest Investment Management Inc. OR and AMF Pensionsforsakring AB. Company insiders that have sold Thermo Fisher Scientific stock in the last year include Alan J Malus, C Martin Harris, Daniel P Shine, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald.
Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?
Thermo Fisher Scientific's stock was bought by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Russell Investments Group Ltd., Janus Capital Management LLC, Renaissance Technologies LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Levin Capital Strategies L.P., Asset Management One Co. Ltd. and State Street Corp.
How do I buy Thermo Fisher Scientific stock?
Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Thermo Fisher Scientific stock cost?
One share of Thermo Fisher Scientific stock can currently be purchased for approximately $158.02.